Stabilised diesel fuel additive compositions
    1.
    发明授权
    Stabilised diesel fuel additive compositions 有权
    稳定的柴油添加剂组合物

    公开(公告)号:US08147568B2

    公开(公告)日:2012-04-03

    申请号:US10932462

    申请日:2004-09-01

    Abstract: A diesel fuel composition containing metallic additives that are stabilized against phase separation. The diesel fuel contains a colloidally dispersed or solubilized metal catalyst compound, which can be used for diesel particulate trap regeneration and, as a stabilizer, 5-1,000 ppm (weight) of an oil-soluble or oil-dispersible organic compound having a lipophilic hydrocarbyl chain having attached directly thereto at least two contiguous polar head functional groups, i.e., the functional groups are separated by no more than three carbon atoms. The diesel fuel composition is particularly suitable for use with diesel engines fitted with a particulate trap for emissions control.

    Abstract translation: 含有稳定相分离的金属添加剂的柴油燃料组合物。 柴油燃料含有胶体分散或溶解的金属催化剂化合物,其可用于柴油颗粒捕集器再生,并且作为稳定剂,5-1000ppm(重量)具有亲油烃基的油溶性或油分散性有机化合物 链直接连接至少两个邻接的极性头官能团,即官能团由不超过三个碳原子分开。 柴油燃料组合物特别适用于配备有用于排放控制的颗粒捕集器的柴油发动机。

    Method of Supplying Iron to the Particulate Trap of a Diesel Engine Exhaust
    2.
    发明申请
    Method of Supplying Iron to the Particulate Trap of a Diesel Engine Exhaust 有权
    向柴油发动机排气的颗粒捕集器提供铁的方法

    公开(公告)号:US20100101211A1

    公开(公告)日:2010-04-29

    申请号:US12593084

    申请日:2008-03-07

    Abstract: The invention concerns a method for supplying iron, via the fuel, to the particulate trap of a diesel engine exhaust in a form suitable for promoting trap regeneration. The method involves the addition to the fuel of a defined colloid of iron oxide. Combustion of this colloid produces iron-containing compounds, especially iron oxides, which collect in association with carbonaceous particulate matter in the particulate trap, and function to promote the combustion of this matter.The colloid in particular shows a lower level of associated deposit formation on the fuel injectors than the iron additives of the prior art. The method is thus particularly suitable for modern engines showing increased susceptibility to fuel injector deposits. The colloid also shows a balance of properties providing excellent suitability for use as an additive in fuels, and especially in diesel engine on-board dosing devices.

    Abstract translation: 本发明涉及一种通过燃料将铁供应到适于促进陷阱再生的形式的柴油发动机排气的颗粒捕集器的方法。 该方法包括加入定义的氧化铁胶体的燃料。 该胶体的燃烧产生含铁化合物,特别是氧化铁,其与颗粒捕集器中的碳质颗粒物质相结合,并且促进该物质的燃烧。 胶体特别表现出比现有技术的铁添加剂更低水平的燃料喷射器上相关的沉积物形成。 因此,该方法特别适用于显示对燃料喷射器沉积物的敏感性增加的现代发动机。 胶体还显示了在燃料中尤其是柴油发动机车载计量装置中特别适合用作燃料添加剂的性能的平衡。

    Method of supplying iron to the particulate trap of a diesel engine exhaust
    5.
    发明授权
    Method of supplying iron to the particulate trap of a diesel engine exhaust 有权
    向柴油发动机排气的颗粒捕集器供给铁的方法

    公开(公告)号:US08641791B2

    公开(公告)日:2014-02-04

    申请号:US12593084

    申请日:2008-03-07

    Abstract: The invention concerns a method for supplying iron, via the fuel, to the particulate trap of a diesel engine exhaust in a form suitable for promoting trap regeneration. The method involves the addition to the fuel of a defined colloid of iron oxide. Combustion of this colloid produces iron-containing compounds, especially iron oxides, which collect in association with carbonaceous particulate matter in the particulate trap, and function to promote the combustion of this matter.The colloid in particular shows a lower level of associated deposit formation on the fuel injectors than the iron additives of the prior art. The method is thus particularly suitable for modern engines showing increased susceptibility to fuel injector deposits. The colloid also shows a balance of properties providing excellent suitability for use as an additive in fuels, and especially in diesel engine on-board dosing devices.

    Abstract translation: 本发明涉及一种通过燃料将铁供应到适于促进陷阱再生的形式的柴油发动机排气的颗粒捕集器的方法。 该方法包括加入定义的氧化铁胶体的燃料。 该胶体的燃烧产生含铁化合物,特别是氧化铁,其与颗粒捕集器中的碳质颗粒物质相结合,并且促进该物质的燃烧。 胶体特别表现出比现有技术的铁添加剂更低水平的燃料喷射器上相关的沉积物形成。 因此,该方法特别适用于显示对燃料喷射器沉积物的敏感性增加的现代发动机。 胶体还显示了在燃料中尤其是柴油发动机车载计量装置中特别适合用作燃料添加剂的性能的平衡。

    Cores for technetium radiopharmaceuticals
    6.
    发明授权
    Cores for technetium radiopharmaceuticals 失效
    锝放射性药物的核心

    公开(公告)号:US6001979A

    公开(公告)日:1999-12-14

    申请号:US774299

    申请日:1996-12-24

    CPC classification number: C07B59/004

    Abstract: A synth .sup.99m Tc complex which contains the moiety Tc.dbd.NR, Tc--N.dbd.NY or Tc(--N.dbd.NY).sub.2 and an organic ligand which confers biological target-seeking properties on the technetium complex, where R is an aryl group, a substituted or unsubstituted alkyl group or the group --NR.sup.1 R.sup.2 ; Y is an aryl group or a substituted or unsubstituted alkyl group; and R.sup.1 and R.sup.2 are H, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different provided that both are not hydrogen. Radiopharmaceuticals comprising this complex are also described, together with methods for the preparation of the complex.

    Abstract translation: 包含部分Tc = NR,Tc-N = NY或Tc(-N = NY)2的合成99mTc复合物和赋予锝络合物上的生物寻靶特性的有机配体,其中R是芳基, 取代或未取代的烷基或基团-NR1R2; Y是芳基或取代或未取代的烷基; 并且R 1和R 2是H,芳基或取代或未取代的脂族或环状烷基,并且相同或不同,条件是两者不是氢。 还描述了包含该复合物的放射性药物,以及制备复合物的方法。

    Cores for technetium radiopharmaceuticals
    7.
    发明授权
    Cores for technetium radiopharmaceuticals 失效
    锝放射性药物的核心

    公开(公告)号:US5589576A

    公开(公告)日:1996-12-31

    申请号:US289654

    申请日:1994-08-12

    CPC classification number: A61K51/0476 A61K51/0478 A61K2123/00

    Abstract: Novel complexes of technetium (.sup.99 Tc or .sup.99m Tc) which contain the moiety Tc.dbd.NR, Tc--N.dbd.NY or Tc(--N.dbd.NY).sub.2, and a ligand which confers biological target-seeking properties on the complex, wherein R represents an aryl group, a substituted or unsubstituted alkyl group, or the grouping .dbd.NR.sup.1 R.sup.2 ; Y represents an aryl group or a substituted or unsubstituted alkyl group; and R.sup.1 and R.sup.2 are hydrogen, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and may be both the same or different, provided that both are not hydrogen. The complexes are suitable for use in radiopharmaceuticals for a variety of clinical applications. Methods for the preparation of these technetium complexes are also described.

    Abstract translation: 含有部分Tc = NR,Tc-N = NY或Tc(-N = NY)2的锝(99Tc或99mTc)的新型络合物和赋予复合物生物靶寻求性质的配体,其中R表示 芳基,取代或未取代的烷基,或基团= NR 1 R 2; Y表示芳基或取代或未取代的烷基; 并且R 1和R 2是氢,芳基或取代或未取代的脂族或环状烷基,并且可以相同或不同,条件是两者都不是氢。 该配合物适用于各种临床应用的放射性药物。 还描述了制备这些锝络合物的方法。

    Cores for technetium radiopharmaceuticals
    8.
    发明授权
    Cores for technetium radiopharmaceuticals 失效
    锝放射性药物的核心

    公开(公告)号:US06329513B1

    公开(公告)日:2001-12-11

    申请号:US09568550

    申请日:2000-05-11

    CPC classification number: C07B59/004

    Abstract: A 99mTc complex which contains the moiety Tc═NR, Tc—N═NY or Tc(—N═NY)2, and as a synthetic organic ligand which confers biological target-seeking properties on the technetium complex, where: R is an aryl group, a substituted or unsubstituted alkyl group or the group —NR1R2; Y is an aryl group or a substituted or unsubstituted alkyl group; R1 and R2 are H, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different provided that both are not hydrogen; where at least one of the R or Y groups comprises an aryl group which chelates the 99mTc.

    Abstract translation: 包含部分Tc = NR,Tc-N = NY或Tc(-N = NY)2的99mTc复合物,以及赋予锝络合物上的生物寻靶特性的合成有机配体,其中:R是芳基 基团,取代或未取代的烷基或基团-NR1R2; Y是芳基或取代或未取代的烷基; R1和R2是H,芳基或取代或未取代的脂族或环状烷基,并且相同或 不同的是两者都不是氢;其中R或Y基团中的至少一个包括螯合99mTc的芳基。

    Cores for technetium radiopharmaceuticals
    9.
    发明授权
    Cores for technetium radiopharmaceuticals 失效
    锝放射性药物的核心

    公开(公告)号:US6124440A

    公开(公告)日:2000-09-26

    申请号:US431098

    申请日:1999-11-01

    CPC classification number: C07B59/004

    Abstract: .sup.99m Tc complexes of formula L.sub.n Tc.dbd.NR, L.sub.n Tc--N.dbd.NY, or L.sub.n Tc--(N.dbd.NY).sub.2 wherein each L is independently a monodentate or multidentate ligand;Y is a substituted or unsubstituted aryl group or substituted or unsubstituted alkyl group;R is Y or the grouping --NR.sup.1 R.sup.2 ;n is 1-4;where at least one of R or Y is combined with one or more of the L groups; R.sup.1 and R.sup.2 are H, substituted or unsubstituted aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different, provided that both are not hydrogen.

    Abstract translation: 式LnTc = NR,LnTc-N = NY或LnTc-(N = NY)2的99mTc配合物,其中每个L独立地是单齿或多齿配体; Y是取代或未取代的芳基或取代或未取代的烷基; R为Y或分组-NR1R2; n为1-4; 其中R或Y中的至少一个与一个或多个L基团组合; R 1和R 2是H,取代或未取代的芳基或取代或未取代的脂族或环状烷基,并且相同或不同,条件是两者都不是氢。

    Cores for technetium radiopharmaceuticals
    10.
    发明授权
    Cores for technetium radiopharmaceuticals 失效
    锝放射性药物的核心

    公开(公告)号:US06515112B2

    公开(公告)日:2003-02-04

    申请号:US09976014

    申请日:2001-10-15

    CPC classification number: C07B59/004

    Abstract: A 99mTc complex which contains the moiety Tc═NR, Tc—N═NY or Tc(—N═NY)2, and as a synthetic organic ligand which confers biological target-seeking properties on the technetium complex, where: R is an aryl group, a substituted or unsubstituted alkyl group or the group —NR1R2; Y is an aryl group or a substituted or unsubstituted alkyl group; R1 and R2 are H, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different provided that both are not hydrogen; where at least one of the R or Y groups comprises an aryl group which chelates the 99mTc.

    Abstract translation: 包含部分Tc = NR,Tc-N = NY或Tc(-N = NY)2的99mTc复合物,以及赋予锝络合物上的生物寻靶特性的合成有机配体,其中:R是芳基 基团,取代或未取代的烷基或基团-NR1R2; Y是芳基或取代或未取代的烷基; R1和R2是H,芳基或取代或未取代的脂族或环状烷基,并且相同或 不同的是两者都不是氢;其中R或Y基团中的至少一个包括螯合99mTc的芳基。

Patent Agency Ranking